Oruka Therapeutics Inc. (ORKA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oruka Therapeutics Inc.

    NASDAQ: ORKA · Real-Time Price · USD
    19.79
    0.61 (3.18%)
    At close: Oct 03, 2025, 3:59 PM
    19.40
    -1.97%
    After-hours: Oct 03, 2025, 05:53 PM EDT

    Oruka Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.89 -55.08 -41.29 -18.57
    PEG Ratio
    		 -0.31 1.19 0.82 -0.19
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.85 7.94 9.83 7.03
    P/FCF Ratio
    		 -5.61 n/a -37.55 -19.08
    P/OCF Ratio
    		 -5.63 n/a -37.56 -19.12
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.00 0.01 0.01 0.01
    Quick Ratio
    		 28.89 59.01 37.72 15.56
    Current Ratio
    		 28.89 59.01 37.72 15.56
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -60.03 n/a n/a n/a
    Return on Equity
    		 -0.22 -0.14 -0.24 -0.38
    Return on Assets
    		 -0.21 -0.14 -0.23 -0.35
    Return on Invested Capital
    		 -0.23 -0.2 -0.23 -0.38
    Dividend Yield
    		 1.00 n/a n/a n/a
    Payout Ratio
    		 -3.88 n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist